Literature DB >> 26546463

Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex.

Pablo Sánchez-Martín1, Carlos Romá-Mateo2, Rosa Viana1, Pascual Sanz3.   

Abstract

Lafora disease (LD, OMIM254780, ORPHA501) is a rare neurodegenerative form of epilepsy related to mutations in two proteins: laforin, a dual specificity phosphatase, and malin, an E3-ubiquitin ligase. Both proteins form a functional complex, where laforin recruits specific substrates to be ubiquitinated by malin. However, little is known about the mechanism driving malin-laforin mediated ubiquitination of its substrates. In this work we present evidence indicating that the malin-laforin complex interacts physically and functionally with the ubiquitin conjugating enzyme E2-N (UBE2N). This binding determines the topology of the chains that the complex is able to promote in the corresponding substrates (mainly K63-linked polyubiquitin chains). In addition, we demonstrate that the malin-laforin complex interacts with the selective autophagy adaptor sequestosome-1 (p62). Binding of p62 to the malin-laforin complex allows its recognition by LC3, a component of the autophagosomal membrane. In addition, p62 enhances the ubiquitinating activity of the malin-laforin E3-ubiquitin ligase complex. These data enrich our knowledge on the mechanism of action of the malin-laforin complex as an E3-ubiquitin ligase and reinforces the role of this complex in targeting substrates toward the autophagy pathway.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagosome; E2-conjugase; E3-ubiquitin ligase; LC3; Laforin; Malin; UBE2N; Ubiquitination; p62 (SQSTM1)

Mesh:

Substances:

Year:  2015        PMID: 26546463     DOI: 10.1016/j.biocel.2015.10.030

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

Review 1.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 2.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

3.  Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.

Authors:  Pablo Sanchez-Martin; Marcos Lahuerta; Rosa Viana; Erwin Knecht; Pascual Sanz
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-11-21       Impact factor: 4.739

Review 4.  Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

Authors:  M Kathryn Brewer; Matthew S Gentry
Journal:  Adv Neurobiol       Date:  2019

Review 5.  Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Martin Steup; Berge A Minassian; Felix Nitschke
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

6.  Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.

Authors:  Felix Nitschke; Mitchell A Sullivan; Peixiang Wang; Xiaochu Zhao; Erin E Chown; Ami M Perri; Lori Israelian; Lucia Juana-López; Paola Bovolenta; Santiago Rodríguez de Córdoba; Martin Steup; Berge A Minassian
Journal:  EMBO Mol Med       Date:  2017-07       Impact factor: 12.137

Review 7.  Lafora Disease: A Ubiquitination-Related Pathology.

Authors:  Maria Adelaida García-Gimeno; Erwin Knecht; Pascual Sanz
Journal:  Cells       Date:  2018-07-26       Impact factor: 6.600

Review 8.  Lafora disease: Current biology and therapeutic approaches.

Authors:  S Mitra; E Gumusgoz; B A Minassian
Journal:  Rev Neurol (Paris)       Date:  2021-07-21       Impact factor: 4.313

9.  Systems Genetics Approaches in Rat Identify Novel Genes and Gene Networks Associated With Cardiac Conduction.

Authors:  Michiel E Adriaens; Elisabeth M Lodder; Aida Moreno-Moral; Jan Šilhavý; Matthias Heinig; Charlotte Glinge; Charly Belterman; Rianne Wolswinkel; Enrico Petretto; Michal Pravenec; Carol Ann Remme; Connie R Bezzina
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

10.  Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.

Authors:  Olga Varea; Jordi Duran; Mònica Aguilera; Neus Prats; Joan J Guinovart
Journal:  Neurobiol Dis       Date:  2020-11-07       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.